# K092257: Jaloskin

- Pathway: 510(k) (Traditional)
- Applicant: Fidia Advanced Biopolymers Srl
- Decided: Jan 26, 2010 after 182 days
- Product code: FRO (Dressing, Wound, Drug)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K881854 (1988). 15 ancestors in all.
No later device cites it as a predicate yet.
0 of 16 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K001508: Laserskin Dressing, Fidia Advanced Biopolymers Srl (2001)
- K073251: Hyalomatrix PA, Fidia Advanced Biopolymers Srl (2007) Summary page 1.

## Indications for use
JALOSKIN is indicated for the management of superficial moderately exuding wounds including pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, skin tears) and first and second degree burns.

Source page: https://510kreport.com/device/K092257
Methodology: https://510kreport.com/methodology